---
title: 'Case report: Advanced age at transplantation and pre-emptive treatment with
  dupilumab in DOCK8 deficiency'
date: '2025-02-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39936153/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250212170950&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Dedicator of cytokinesis 8 (DOCK8) deficiency is a combined immunodeficiency
  (CID) due to biallelic mutations in the gene encoding DOCK8. Major clinical phenomena
  are recurrent severe infections of the lungs and skin, atopic eczema, and predisposition
  to malignancy leading to a poor prognosis. Typical findings include highly elevated
  IgE and eosinophilia. Allogeneic hematopoietic stem cell transplantation (alloHSCT)
  is indicated as the only curative treatment option. We present a patient ...
disable_comments: true
---
Dedicator of cytokinesis 8 (DOCK8) deficiency is a combined immunodeficiency (CID) due to biallelic mutations in the gene encoding DOCK8. Major clinical phenomena are recurrent severe infections of the lungs and skin, atopic eczema, and predisposition to malignancy leading to a poor prognosis. Typical findings include highly elevated IgE and eosinophilia. Allogeneic hematopoietic stem cell transplantation (alloHSCT) is indicated as the only curative treatment option. We present a patient ...